Highmark BCBS Medical Policy Updates – September 2018

Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates »

September 2018 Medical Policy Updates:

• Vitamin D Assay
• Anesthesia Provided in Conjunction with Non-covered Services
• Bio-Engineered Skin and Soft Tissue Substitutes
• Carboplatin (Paraplatin)
• Cetuximab (Erbitux)
• Chemodenervation-Botulinum Toxin
• Diagnosis and Treatment of Obstructive Sleep Apnea for Adults
• Diagnosis and Treatment of Obstructive Sleep Apnea in Children
• Docetaxel (Taxotere)
• Electrical Nerve Stimulation
• Electroencephalogram (EEG) Technologies
• Esophageal pH Monitoring
• Experimental/Investigational Services
• Gait Analysis
• Granulocyte Colony-Stimulating Factors
• Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
• Hip Arthroplasty – Total and Partial
• Hip Surgery Arthroscopic and Open Procedures
• Implantable Intrathecal Drug Delivery Systems
• Inhalation Products for the Management of Cystic Fibrosis
• Interferon Alpha
• Intraoperative Neurophysiologic Monitoring (Sensory-Evoked Potentials, Motor-Evoked Potentials, EEG Monitoring)
• Ipilimumab (Yervoy)
• Kyphoplasty
• Lung and Lobar Lung Transplantation
• Magnetic Esophageal Ring to Treat Gastroesophageal Reflux Disease (LINX®)
• Medical Nutrition Management Services (MNT)
• Meniscal Allograft Transplantation
• Mohs Micrographic Surgery (MMS)
• Monoclonal Antibodies for the Treatment of Eosinophilic Conditions
• Natalizumab (Tysabri®)
• Nerve Conduction Velocity Studies (NVC) and Electromyography (EMG)
• Nerve Conduction Velocity Studies (NVC) and Electromyography (EMG)
• Obesity
• Omalizumab (Xolair)
• Organ or Disease Oriented Panels
• Paclitaxel (Taxol)
• Paclitaxel, albumin-bound (Abraxane)
• Pain Management of Peripheral Nerves by Injection
• Pap Smears with Medical Conditions
• Pemetrexed (Alimta®)
• Percutaneous Intracranial and Extracranial Balloon Angioplasty With or Without Stenting
• Photodynamic Therapy (PDT) with Porfimer Sodium
• Plerixafor (Mozobil”!)
• Programmed Death Receptor (PD-1)/ Programmed Death-Ligand (PD-L1) Blocking Antibodies
• Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors
• Radiofrequency Joint Ablation-Denervation
• Removal of Benign or Premalignant Skin Lesions
• Sacroiliac Joint Injections
• Surgical Treatment of Varicose Veins
• Telestroke
• Treatment of Abnormal Uterine Bleeding and Fibroids
• Treatment of Hereditary Angioedema (HAE)
• Vitamin D Assay
• Wearable Cardioverter-Defibrillator
• Wheelchairs (WC) and Options/Accessories
• Ziconotide (Prialt®)

Click here to the view the Highmark Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.